Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -50.34% | -59.44% | - | - | 92.63K | ||
| -1.21% | -5.37% | +39.94% | +145.38% | 992B | ||
| -2.48% | -4.17% | +51.52% | +39.07% | 564B | ||
| -2.14% | -3.68% | +16.71% | +56.15% | 391B | ||
| -1.18% | +0.25% | +25.86% | +16.53% | 330B | ||
| -2.36% | -3.12% | +24.71% | +11.59% | 280B | ||
| -2.45% | -2.88% | +24.29% | +30.06% | 279B | ||
| -1.91% | -0.87% | -41.95% | -49.25% | 196B | ||
| -1.19% | -4.65% | +16.56% | +47.00% | 184B | ||
| -1.35% | -1.68% | +14.59% | +56.94% | 156B | ||
| Average | -6.66% | -1.98% | +19.14% | +39.27% | 374.58B | |
| Weighted average by Cap. | -1.77% | -2.88% | +28.03% | +63.21% |
Employees
4
Sector
Pharmaceuticals
















